65,437 trials
Influenza · Healthy Volunteers
Primary: Geometric Mean of Hemagglutination Inhibition (HAI) Antibody (Ab) Titer at Day 22 — 5.74; 5.61; 5.28 titer
Neoplasms by Site
Primary: Maximum Observed Serum Nivolumab Concentration (Cmax) - Parts A, B, D, and E — 54.8; 56.6; 81.4; 63.9 ug/mL
Acute Migraine
Primary: Treatment Safety Period: Number of Participants With Treatment Emergent Adverse Events (TEAEs) — 203 Participants
Cardiac Rhythm Disorder · Bradycardia · Cardiac Pacemaker Artificial
Primary: Mean Rankings for Pacemaker Device Features — 2.3; 2.6; 2.2; 4.7 score on a scale
Cocaine Use Disorder · Methamphetamine Abuse · Cocaine Dependence
Primary: Percentage of Participants Who Receive at Least 20 Sessions of rTMS/Sham Over the Treatment Period. — 29; 40; 37; 23 Participants
Urinary Incontinence
Primary: Residual Volume at 1st Flow-stop (Catheterisation Performed by HCP) — 23.22; 15.87 milliliters
Stress Disorders, Post-Traumatic · Depressive Symptoms · Hydrocortisone
Primary: Post-traumatic Stress Symptoms (PTSD) as Measured by the PTSD Checklist for DSM 5 (PCL-5) (DSM=Diagnostic and Statistical Manuel of Mental Disorders). — 26.93; 30.75…
Deglutition Disorders
Primary: Numbers of Participants for Which the Aspirometer/HRCA Predicted the Passed Versus Failed Swallow Test Result — 4; 12 Participants
Syndesmotic Injuries · Ligament Rupture · Bimalleolar Fractures
Primary: Syndesmotic Volumetric Ratio — 1.2; 1.1 Volumetric Ratio
Metastatic Pancreatic Adenocarcinoma · Recurrent Pancreatic Adenocarcinoma · Stage IV Pancreatic Cancer AJCC v6 and v7
Primary: Overall Response Rate — 1 Participants
Depression, Anxiety
Primary: Working Alliance Inventory-Short Revised (WAI-SR), Total Scale — 3.63; 3.25; 3.95; 3.61 score on a scale
Anxiety
Primary: Change in Recognition Ratings (Positive Interpretation Bias) — 2.40; 2.29; 2.29; 2.30 units on a scale
Ridge Preservation
Primary: Changes in Width of Extraction Site (Ridge) — 0.7; 1.3 mm — p=<0.05
Arterial Occlusion · Cardiovascular Diseases · Hematoma
Primary: Time to Hemostasis — 5.11; 4.3 minutes
Urinary Incontinence
Primary: International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF) — 7.0; 9.8 score on a scale — p=0.001